Clinical Trial: A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749651) titled 'A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults' on Aug. 03.

Brief Summary: A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Cutaneous Lupus Erythematosus(CLE)

Intervention: DRUG: SHR-7012 injection ; placebo

A single subcutaneous injection of Dose1 SHR-7012 injection or placebo was administered

DRUG: SHR-7012 injection ; placebo

A single subcutaneous injection of Dose2 SHR-7012 injection or placebo was administe...